Processa Pharmaceuticals (PCSA) Other Working Capital Changes (2013 - 2026)

Processa Pharmaceuticals (PCSA) has reported Other Working Capital Changes for 10 consecutive years, with $156960.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Working Capital Changes rose 125.49% year-over-year to $156960.0; the trailing twelve-month figure through Jun 2026 stood at $181587.0 (up 126.09% YoY), and the FY2025 full-year result was -$834651.0, down 181.0% from the prior year.
• Other Working Capital Changes improved to $156960.0 in Q2 2026 per PCSA's latest filing, from $113444.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $1.0 million in Q2 2024 and bottomed at -$615839.0 in Q2 2025.
• Historically, Other Working Capital Changes has averaged -$38955.2 across 5 years, with a median of -$61999.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes surged 507.67% in 2024, then slumped 1535.47% in 2025.
• Over 5 years, Other Working Capital Changes stood at $88525.0 in 2022, then slumped by 236.11% to -$120490.0 in 2023, then soared by 108.35% to $10061.0 in 2024, then sank by 1535.47% to -$144423.0 in 2025, then soared by 208.68% to $156960.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $156960.0, $113444.0, and -$144423.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.